Cookie Consent by PrivacyPolicies.com

November 16, 2021

BAHIA SOFTWARE attends MEDICA 2021

Date: November 16th 2021


Sergio Figueiras, Innovation Director of BAHIA SOFTWARE, a partner company of the HUTER project, is attending MEDICA 2021 trade fair at Dusseldorf. During this large event, he will share the first results of HUTER platform with research organizations and Manufacturers/distributors of medical equipment.


The MEDICA trade fair at Dusseldorf is a must event for anyone who wants to experience tomorrow’s world of medicine. As a member of the HUTER project, BAHIA SOFTWARE developed a state of the art platform that manages and integrates complex single cell data (imaging, genomics, transcriptomics, etc). This is the first step not only to cell map the human uterus but also to exploit valuable information for revolutionary diagnostics and therapies.


During his first day at MEDICA Sergio met several companies and organizations. Most of them were working on whole exome sequencing technologies applied to different diseases like cancer. But all of them were aware of the potential of single cell RNA seq and single cell transcriptomics and they appreciated the level of data integration of the HUTER platform as a cloud solution. In these meetings, the representatives of the interviewed companies also appreciated the promising perspectives of single cell technologies in the near future.


Sergio Figueiras will be present at MEDICA Dusseldorf until the final day of the event on November 18th. Anyone interested in a meeting with him or with other BAHIA SOFTWARE colleagues should contact him through innovation@bahiasoftware.es.


About the Human Uterus Cells Atlas – HUTER


The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women ́s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.


The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity.


HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.


Link to the project website: https://huter-hca.eu/